A total of 34 patients with ITP were being treated with thrombopoietin receptor agonists (TPO-RA), 4 with corticoids, 2 with immune globulin intravenous (IGIV), and 7 with combined schemes (corticoids and IGIV). Here, MPL is linked to autoimmune thrombocytopenic purpura.